El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) Key Statistics
26 reported figures for El-Nile Co. for Pharmaceuticals & Chemical Industries — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 16.75B
- P/E (trailing)
- 54.29
- P/B
- 20.49
- Dividend yield
- 0.6%
Income (latest fiscal year)
- Revenue
- EGP 1.29B
- Net income
- EGP 125.73M
- EBITDA
- EGP 374.19M
- Free cash flow
- EGP -472.82M
- Profit margin
- 9.75%
Balance sheet
- Total assets
- EGP 2.32B
- Total debt
- EGP 988.73M
- Book value
- EGP 743.29M
Growth
- Revenue growth
- 12.86%
- Profit growth
- 39.35%
- EPS growth
- 18.21%
Per share
- EPS (fiscal year)
- 2.79
- Book value per share
- 16.49
- Dividend per share
- 2
- Return on equity
- 20.74%
- Return on assets
- 6.63%
Technical
- RSI (14)
- 51.3
- 50-day moving average
- EGP 287.32
- 200-day moving average
- EGP 158.38
- Beta (1Y)
- 0.82
Shares
- Shares outstanding
- 50M
- Free float
- 28.33%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.